Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 16

1.

Proton Pump Inhibitor Therapy Is Associated With Reduction of Early Bleeding Risk After Prophylactic Endoscopic Variceal Band Ligation: A Retrospective Cohort Study.

Kang SH, Yim HJ, Kim SY, Suh SJ, Hyun JJ, Jung SW, Jung YK, Koo JS, Lee SW.

Medicine (Baltimore). 2016 Feb;95(8):e2903. doi: 10.1097/MD.0000000000002903.

2.

After proper optimization of carvedilol dose, do different child classes of liver disease differ in terms of dose tolerance and response on a chronic basis?

Wani ZA, Baht RA, Bhadoria AS, Maiwall R, Majeed Y, Khan AA, Zargar SA, Shah MA, Khan KM.

Saudi J Gastroenterol. 2015 Sep-Oct;21(5):278-83. doi: 10.4103/1319-3767.164207.

3.

Primary prophylaxis of bleeding from esophageal varices in cirrhosis.

Merkel C, Montagnese S, Amodio P.

J Clin Exp Hepatol. 2013 Sep;3(3):198-203. doi: 10.1016/j.jceh.2013.08.002. Epub 2013 Sep 7. Review.

4.

The comparison of esophageal variceal ligation plus propranolol versus propranolol alone for the primary prophylaxis of esophageal variceal bleeding.

Je D, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Clin Mol Hepatol. 2014 Sep;20(3):283-90. doi: 10.3350/cmh.2014.20.3.283. Epub 2014 Sep 25.

5.

Pathogenesis and management of alcoholic liver cirrhosis: a review.

Huang YW, Yang SS, Kao JH.

Hepat Med. 2011 Dec 24;3:1-11. doi: 10.2147/HMER.S10265. Review.

6.

Prevention and management of variceal hemorrhage.

Kim DH, Park JY.

Int J Hepatol. 2013;2013:434609. doi: 10.1155/2013/434609. Epub 2013 Mar 31.

7.

Gamna-Gandy bodies of the spleen detected with susceptibility weighted imaging: maybe a new potential non-invasive marker of esophageal varices.

Zhang J, Tao R, You Z, Dai Y, Fan Y, Cui J, Mao Q, Wang J.

PLoS One. 2013;8(1):e55626. doi: 10.1371/journal.pone.0055626. Epub 2013 Jan 31.

8.

Endoscopic management of esophageal varices.

Poza Cordon J, Froilan Torres C, Burgos García A, Gea Rodriguez F, Suárez de Parga JM.

World J Gastrointest Endosc. 2012 Jul 16;4(7):312-22. doi: 10.4253/wjge.v4.i7.312.

9.

Improving survival in decompensated cirrhosis.

Mukerji AN, Patel V, Jain A.

Int J Hepatol. 2012;2012:318627. doi: 10.1155/2012/318627. Epub 2012 Jul 2.

10.

Prevention and management of gastroesophageal varices in cirrhosis.

Chen YI, Ghali P.

Int J Hepatol. 2012;2012:750150. doi: 10.1155/2012/750150. Epub 2012 Apr 22.

11.

Treatment of portal hypertension.

Bari K, Garcia-Tsao G.

World J Gastroenterol. 2012 Mar 21;18(11):1166-75. doi: 10.3748/wjg.v18.i11.1166. Review.

12.

Application of endoscopy in improving survival of cirrhotic patients with acute variceal hemorrhage.

Hsu YC, Chung CS, Wang HP.

Int J Hepatol. 2011;2011:893973. doi: 10.4061/2011/893973. Epub 2011 Jul 21.

13.

Prediction of large esophageal varices in cirrhotic patients using classification and regression tree analysis.

Hong WD, Dong LM, Jiang ZC, Zhu QH, Jin SQ.

Clinics (Sao Paulo). 2011;66(1):119-24.

14.

Carvedilol in the treatment of portal hypertension.

Al-Ghamdi H.

Saudi J Gastroenterol. 2011 Mar-Apr;17(2):155-8. doi: 10.4103/1319-3767.77251. Review.

15.

Retrospective studies with inconsistent data: results, conclusions and recommendations should be taken with a grain of salt.

AlTraif I.

Saudi J Gastroenterol. 2011 Mar-Apr;17(2):93-4. doi: 10.4103/1319-3767.77235. No abstract available.

16.

Clinical pharmacology of portal hypertension.

Miñano C, Garcia-Tsao G.

Gastroenterol Clin North Am. 2010 Sep;39(3):681-95. doi: 10.1016/j.gtc.2010.08.015. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk